• Caveolin-1, Cholesterol, and MASLD Progression

  2026-08-21

  The reference study identifies caveolin-1 as a regulator of hepatic cholesterol homeostasis whose loss intensifies endoplasmic reticulum stress and pyroptosis during MASLD progression. By combining CAV1-deficient mice, liver transcriptomics, human samples, and cellular assays, the authors connect the CAV1–FXR/NR1H4–ABCG5/ABCG8 axis to a mechanistic disease model that can guide future cholesterol-focused investigations.

• Bifendate (DDB): Applied Liver Research Workflows

  2026-08-20

  Build reproducible Bifendate (DDB) experiments around hepatoprotection, lipid metabolism, autophagy flux, and CYP3A4 interaction testing. This guide translates product specifications and a clinically validated CYP-induction workflow into practical cell, hepatocyte, and animal-study decisions.

• Premature Stimulation Expands Atrial Slow Conduction

  2026-08-20

  Lange and colleagues showed that premature stimulation enlarges pre-existing slow-conduction regions in atrial tissue from goats with persistent atrial fibrillation, rather than primarily creating new regions. Their optical-mapping framework links pacing-dependent electrophysiology with spatial lesion architecture and offers a practical strategy for evaluating arrhythmogenic substrate dynamics.

• Sodium Oxamate: LDH-A Workflow & Use Cases

  2026-08-19

  Sodium Oxamate is a practical LDH-A probe for separating lactate production from downstream signaling, making it useful in cancer metabolism research and tissue-injury models. This guide translates recent white matter injury findings into dose design, orthogonal readouts, and troubleshooting strategies for Oxamic Acid sodium salt experiments.

• Latrunculin B: Actin Dynamics Workflow Guide

  2026-08-19

  Latrunculin B enables short, controllable actin filament assembly inhibition for imaging, cytoskeletal organization studies, and pathway-discrimination experiments. This guide combines practical dosing and recovery workflows with evidence from a reovirus entry study showing why actin disruption should be tested as a mechanistic control rather than assumed to block every endocytic route.

• SOAT1, Lipophagy, and PHMG Pulmonary Fibrosis

  2026-08-18

  The reference study identifies SOAT1 as a previously unrecognized mediator of PHMG-induced pulmonary fibrosis, linking alveolar-macrophage cholesterol ester accumulation to defective lipophagy and profibrotic signaling. Its in vivo and in vitro evidence supports SOAT1 inhibition with avasimibe as a mechanistically grounded preclinical strategy, while also highlighting cholesterol homeostasis as an important endpoint for future toxicology studies.

• Dextromethorphan Hydrobromide: NMDA Research

  2026-08-18

  Dextromethorphan hydrobromide is a research-grade NMDA receptor antagonist used to investigate excitotoxicity, ion-channel modulation, and neuroprotection. Its reported activity includes inhibition of NMDA-induced currents and voltage-operated sodium and calcium currents, while its evidence base remains primarily in vitro and preclinical.

• Fluconazole and Mucosal Antifungal Defense

  2026-08-17

  Fluconazole is more than a benchmark antifungal compound: it can help separate fungal membrane stress from host-mediated nutritional immunity. This article integrates Fluconazole assays with new findings on METTL9–PRA1 zinc restriction to improve Candida experimental design.

• Caspofungin Workflows for Candida Research

  2026-08-17

  Caspofungin gives researchers a focused way to interrogate fungal cell wall biosynthesis inhibition, benchmark antifungal susceptibility, and model treatment of azole-resistant Candida. This practical guide connects plate-based assays with delayed-treatment experimental designs and provides troubleshooting advice for reproducible results.

• Icariin–PDE5A Control of Spermatogonial Stem Cells

  2026-08-16

  This study identifies PDE5A as a molecular target through which icariin promotes mouse spermatogonial stem cell viability and DNA synthesis while limiting hydrogen peroxide-associated DNA damage. Its combination of cell-based assays, SPRi, molecular docking, and in vivo reproductive assessment provides a mechanistic framework for evaluating icariin in male reproductive biology.

• BML-277 for Chk2 DNA Damage Studies

  2026-08-15

  BML-277 provides a nanomolar, ATP-competitive route to interrogate Chk2 in biochemical assays, T-cell radioprotection models, and DNA damage signaling. This workflow-oriented guide connects Chk2 perturbation with the nuclear cGAS–TRIM41–ORF2p axis while separating established evidence from practical assay recommendations.

• MCL-1 Dependence in Breast Cancer: What the Study Shows

  2026-08-14

  Campbell and colleagues show that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic control of BAX/BAK, rather than because of an exclusively non-apoptotic function. Genetic deletion and pharmacological inhibition both impaired tumor growth, while removal of BAX and BAK prevented these effects, providing a mechanistic framework for interpreting MCL-1 inhibitor studies in breast cancer.

• 5-Methyl-CTP for Reliable mRNA Assays

  2026-08-14

  A scenario-based guide to using 5-Methyl-CTP (SKU B7967) in modified mRNA synthesis workflows that support cell viability, proliferation, and cytotoxicity studies. It covers experimental controls, stock handling, interpretation, and practical supplier-selection criteria.

• EZ Cap™ Human PTEN mRNA: Workflow Guide

  2026-08-13

  Build reproducible PTEN-restoration assays with a Cap 1, polyadenylated mRNA designed for transient protein expression. This guide connects routine mRNA transfection and expression experiments with emerging hyaluronate-lipid nanoparticle strategies for localized cancer research and gene therapy research.

• Nuclear cGAS, CHK2, and L1 Retrotransposition

  2026-08-13

  The reference study identifies a nuclear DNA-damage pathway in which CHK2-phosphorylated cGAS promotes TRIM41-dependent ubiquitination and degradation of the LINE-1 protein ORF2p. This mechanism links checkpoint signaling to suppression of retrotransposition, with implications for genome integrity, cellular senescence, aging, and cancer research.

15297 records 1/1020 page Next 12345 下5页 Last page